In an effort to identify the KLF5 enhancer region in CRC cells, we used in vitro engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) combined with next-generation sequencing (NGS) (in vitro enChIP-seq) [20, 21]. The gene discussed is KLF5; the disease is colorectal carcinoma.